These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 177803)

  • 1. [Treatment of primary hyperlipoproteinemias type IV with different biguanides (author's transl)].
    Weisweiler P; Schwandt P
    Klin Wochenschr; 1976 Mar; 54(6):283-5. PubMed ID: 177803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].
    Koschinsky T; Gries FA; Schwandt P; Weisweiler P; Hansen W; Nijssen J; Beckmann R
    MMW Munch Med Wochenschr; 1977 May; 119(20):701-4. PubMed ID: 195201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indications and contraindications to the diabetes mellitus therapy by biguanide derivatives in the light of the metabolic and epidemiologic studies (author's transl)].
    Tatoń J; Kowalik-Borówka E
    Przegl Lek; 1979; 36(7):553-7. PubMed ID: 504704
    [No Abstract]   [Full Text] [Related]  

  • 4. [The risk of lacticate acidosis: a comparison of the 3 biguanides in treatment of diabetics (authors' transl)].
    Irsigler K; Kritz H; Regal H; Foltin E
    Wien Klin Wochenschr; 1978 May; 90(10):332-7. PubMed ID: 654296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood lactate and biguanide therapy: comparison between phenformin, metformin and buformin in 408 senile diabetics].
    Bruneder H; Klein HJ
    Acta Med Austriaca; 1978; 5(3):88-90. PubMed ID: 752220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of primary hyperlipoproteinemia type IIb and IV. Comparison of the lipid lowering effect of phenformin, clofibrate, and a combination of both (author's transl)].
    Koschinsky T; Lenhard P; Gries FA; Vogelberg KH; Wolfram G; Lang PD; Vollmar J
    Med Klin; 1977 Sep; 72(38):1537-43. PubMed ID: 904549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypolipidemic effects of metformin in hyperprebetalipoproteinemia.
    Fedele D; Tiengo A; Nosadini R; Marchiori E; Briani G; Garotti MC; Muggeo M
    Diabete Metab; 1976 Sep; 2(3):127-33. PubMed ID: 188698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biguanides: reasons for withdrawal of drugs and remaining indications].
    Bolzano K
    Acta Med Austriaca; 1978; 5(3):85-8. PubMed ID: 752219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypertriglyceridemia with metformin. Effectiveness and analỳsis of results.
    Sirtori CR; Tremoli E; Sirtori M; Conti F; Paoletti R
    Atherosclerosis; 1977 Apr; 26(4):583-92. PubMed ID: 193525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of biguanide therapy on lactate metabolism during graded submaximal ergometric testing].
    Pilger E; Schmid P; Goebel R
    Acta Med Austriaca; 1978; 5(3):91-5. PubMed ID: 752221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correction of endocrine-metabolic disorders in oncologic patients. The effect of biguanides (phenformin and adebita), miskleron and diphenin].
    Dil'man VM; Bershteĭn LM; Tsyrlina EV; Bobrov IuF; Kovaleva IG
    Vopr Onkol; 1975; 21(11):33-9. PubMed ID: 1210118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of bile acid metabolism and vitamin-B12-absorption in diabetics on biguanides.
    Caspary WF; Zavada I; Reimold W; Deuticke U; Emrich D; Willms B
    Diabetologia; 1977 May; 13(3):187-93. PubMed ID: 873086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Semi-automatic determination of blood lactate during hypoglycemic treatment with biguanides].
    Gelo Signorino R; Castellazzi R; Gamba S; Grassi G; Zanno C; Bruni B
    Ann Osp Maria Vittoria Torino; 1979; 22(1-6):18-37. PubMed ID: 122229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The lipid reducing action of phenformin in primary type IV hyperlipoproteinaemia (author's transl)].
    Lang PD; Vollmar J; Klemens UH; von Löwis P; Gries FA; Koschinsky T; Huth K; Pilz E; Schlierf G; Kremer GJ; Lenhart P; Schwandt P; Hammerl H; Studlar M
    Dtsch Med Wochenschr; 1973 Nov; 98(48):2280-6. PubMed ID: 4762828
    [No Abstract]   [Full Text] [Related]  

  • 15. Biguanides.
    Nattrass M; Alberti KG
    Diabetologia; 1978 Feb; 14(2):71-4. PubMed ID: 631459
    [No Abstract]   [Full Text] [Related]  

  • 16. [The influence of clofibrate on elevated serum lactate levels in diabetic patients treated with biguanides (author's transl)].
    Vogelberg KH; Cicmir I; Heggen ME
    Arzneimittelforschung; 1980; 30(4):683-5. PubMed ID: 7190412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biguanides in oral antidiabetic therapy: indications and limitations].
    Gregorio F; Filipponi P
    Medicina (Firenze); 1988; 8(3):262-8. PubMed ID: 3231038
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combination of clofibrate and phenformin in the treatment of endogenous hypertriglyceridaemia (author's transl)].
    Vogelberg KH
    Dtsch Med Wochenschr; 1976 Dec; 101(51):1868-71. PubMed ID: 1001205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biguanide therapy of primary hyperlipoproteinemias type IIb, 3 and IV as monotherapy and combined with clofibrate].
    Koschinsky T; Vogelberg KH; Gries FA
    Verh Dtsch Ges Inn Med; 1973; 79():1294-6. PubMed ID: 4795174
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of hyperlipoproteinemias (author's transl)].
    Crepaldi G; Fellin R; Briani G; Baggio G; Baiocchi MR
    G Ital Cardiol; 1974; 4(3):332-40. PubMed ID: 4367439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.